Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine

Eur J Clin Invest. 2023 Dec;53(12):e14102. doi: 10.1111/eci.14102. Epub 2023 Oct 13.

Authors

Max Schmeling¹, Vibeke Manniche², Peter Riis Hansen^{3

4}

Affiliations

¹ Innometric, Skørping, Denmark.
² LIVA, Copenhagen, Denmark.
³ Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Gentofte Hospitalsvej, Hellerup, Denmark.
⁴ Faculty of Health and Medical Sciences Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

PMID: 37833825
DOI: 10.1111/eci.14102

No abstract available

Publication types

Letter
Comment

MeSH terms

BNT162 Vaccine* / adverse effects
COVID-19* / prevention & control
Humans

Substances

BNT162 Vaccine